A prospective, single-blind, randomized controlled trial of petroleum jelly/Vaseline for recurrent paediatric epistaxis

• Published in: Clinical otolaryngology Vol. 29; no. 3; pp. 266 - 269
• Main Authors: Loughran, S., Spinou, E., Clement, W.A., Cathcart, R., Kubba, H., Geddes, N.K.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01-06-2004; Wiley Subscription Services, Inc
• Subjects: Adolescent; Child; Child, Preschool; Emollients - therapeutic use; epistaxis; Epistaxis - drug therapy; Female; Humans; Infant; Male; Petrolatum - therapeutic use; petroleum jelly; Prospective Studies; randomized controlled trial; Recurrence; Single-Blind Method; Treatment Outcome
• ISSN: 0307-7772; 1749-4478; 1365-2273; 1749-4486
• DOI: 10.1111/j.1365-2273.2004.00813.x

The aim of the study was to determine if petroleum jelly was an effective treatment for paediatric epistaxis. A single‐blind, prospective, randomized controlled trial was undertaken in an otolaryngology outpatient clinic of a paediatric hospital from March 2001 to March 2002. A total of 105 children referred with recurrent epistaxis were randomized into the study, 52 into the treatment arm and 53 into the control arm. Children in the treatment arm applied Vaseline twice a day bilaterally for 4 weeks and were monitored for any bleeds for the next 4 weeks. Children in the control arm were simply given an 8‐week appointment and the number of bleeds were monitored for the 4 weeks prior to their appointment. The outcome measure was the proportion of children in each group without nosebleeds in the preceding 4 weeks. Both groups were equally distributed in age, duration of symptoms and duration of each bleed. Fourteen of 51 (27.5%) patients of the treatment arm and 18 of 53 (34%) of the control arm did not bleed in the 4 weeks before review (chi‐square test, P = 0.472). It can be concluded that Vaseline alone confers no benefit over simple observation in recurrent childhood epistaxis.